AQST

AQUESTIVE THERAPEUTICS INC

AQST·03843E104·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

AQST (AQUESTIVE THERAPEUTICS INC) is held by 90 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($31.2M), RTW INVESTMENTS, LP ($30.8M), FEDERATED HERMES, INC. ($12.2M). Net institutional sentiment: Mixed.

90
Holders
Avg rating(25 Elite)
$184.4M
Total Value
48% (108)
Fund Consensus
48 buying - 52 selling
AQSTSmart Money Verdict
View all
Held by 90 funds
25 elite
Who's Trading
InsiderKJKrop JulieSell $125KJun 23, 2026
InsiderBJBRAENDER LORI JTax 136K shMay 7, 2026
InsiderBDBarber DanielTax 336K shMay 5, 2026
InsiderBJBRAENDER LORI JTax 76K shMay 5, 2026
InsiderTJTOTH A ERNEST JRTax 93K shMay 5, 2026
InsiderBEBoyd Peter E.Tax 57K shMay 5, 2026
InsiderJCJung CassieTax 73K shMay 5, 2026
InsiderBDBarber DanielSell $754KMar 10, 2026
ActivistRTW Investments, LPRTW Investments, LP5.2%Nov 14, 2025
ActivistBlackRock, Inc.BlackRock, Inc.5.3%Oct 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
7.5M(-3.4%)$31.2M0.0%+3.67%
0
Increased
7.4M(+18.8%)$30.8M0.3%-23.81%
41
Increased
2.9M(+44.6%)$12.2M0.0%-24.93%
38
Increased
2.9M(+198.7%)$12M0.0%-15.51%
45
Increased
2.5M(+3.4%)$10.6M0.0%-7.51%
29
Increased
2.4M(+1.7%)$10M0.0%+18.75%
28
Increased
2.4M(+99.2%)$10M0.0%+11.41%
45
Decreased
1.6M(-9.5%)$6.6M0.0%+11.84%
0
Increased
1.1M(+199.0%)$4.7M0.0%-15.50%
43
Increased
1.1M(+6.2%)$4.5M0.0%-25.91%
29
Decreased
1M(-12.9%)$4.3M0.0%-32.22%
0
Increased
1M(+101.1%)$4.3M0.0%-18.23%
43
Increased
878,316(+28.9%)$3.6M0.0%-22.36%
33
Decreased
809,007(-30.9%)$3.4M0.0%-35.15%
0
Increased
799,163(+134.5%)$3.3M0.0%-11.21%
43
Decreased
732,504(-1.4%)$3M0.0%-4.36%
0
Increased
584,977(+103.3%)$2.4M0.0%-4.36%
42
Decreased
565,203(-1.0%)$2.3M0.0%-22.86%
0
Decreased
466,767(-48.6%)$1.9M0.0%-19.79%
0
Increased
464,207(+56.6%)$1.9M0.0%-0.59%
37

Showing 1-20 of 108

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used